Optiray (Ioversol)

Ioversol, the active ingredient in Optiray, is an iodinated contrast agent presented as a sterile injectable solution for intra‑arterial and intravenous use. It provides radiodensity by attenuating X‑rays, enhancing the contrast of vascular and tissue structures during imaging procedures. Optiray is employed to improve visualization in X‑ray, CT and angiographic studies across a range of clinical settings.

GNH USA supplies Optiray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ioversol is used as a radiographic contrast agent to enhance X‑ray and CT imaging.

- X‑ray imaging: improves visualization of vascular and tissue structures. - Computed tomography (CT) angiography: provides high‑contrast images of blood vessels. - Intra‑arterial and intravenous angiography: enhances delineation of arterial and venous anatomy.

Adverse reactions may occur following administration of Ioversol.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste in the mouth. - Mild nausea or vomiting. - Headache or dizziness. - Transient urticaria or mild skin rash.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute renal failure, especially in patients with pre‑existing kidney disease. - Significant hypotension or cardiovascular collapse. - Cardiac arrhythmias. - Pulmonary edema.

Prior to using Optiray, clinicians should consider several safety measures.

- Assess renal function: evaluate serum creatinine and eGFR. - Review allergy history: identify prior reactions to iodinated contrast. - Use the lowest effective dose: limit exposure while achieving diagnostic quality. - Monitor vital signs: observe patient during and after injection. - Avoid in patients with known iodine hypersensitivity or severe renal impairment. - Store at ambient temperature: keep in original container, protect from light and moisture.

Ioversol may interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents. - High‑dose nephrotoxic drugs such as aminoglycosides. - Metformin in patients with impaired renal function.

Moderate Interactions (Monitor Closely): - Diuretics that may affect fluid balance. - ACE inhibitors or ARBs that influence renal perfusion. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) which can exacerbate renal risk. - Thyroid hormone therapy, as iodine load may affect thyroid function.